EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

PSMA radioligand uptake correlates with PSMA expression in high-grade glioma and brain metastasis: insights from a prospective PET-MRI guided multiregional biopsy study

Ilanah J Pruis, Vera van Dis, Sybren L N Maas, Rutger K Balvers, Thierry P P van den Bosch, Marcel Segbers, Sophie E M Veldhuijzen van Zanten iD

European Journal of Nuclear Medicine and Molecular Imaging · 2025-11 · 52 (13) · 4870-4881

DOI: 10.1007/s00259-025-07338-4 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 26.05.2025. Verfasst von Ilanah J Pruis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, University Medical Centre Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Antigens, Surface, Brain Neoplasms, Edetic Acid, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Semmy Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Prostate-specific membrane antigen (PSMA) is a potential target for radioligand therapy (RLT) in neuro-oncology. This study investigates the direct relation between [ 68 Ga]Ga-PSMA-11 uptake on PET and PSMA expression in the tumour micro-environment of high-grade glioma (HGG) and brain metastasis (BM).

Methods

Twelve patients with HGG (glioblastoma n = 6, oligodendroglioma n = 1), or BM (lung- n = 4, breast cancer n = 1), underwent PET-MRI after intravenous [ 68 Ga]Ga-PSMA-11 injection (1.5 MBq/kg), followed by image-guided biopsy sampling during (re-)resection surgery. Multiple samples (median n = 3/patient, n = 23 HGG/ n = 20 BM) from locations of low and high [ 68 Ga]Ga-PSMA-11 uptake were analysed for PSMA expression in vasculature and non-vascular structures using morphology and immunohistochemistry.

Results

All patients showed [ 68 Ga]Ga-PSMA-11 uptake in tumour ( SUVmax median, range: 10.5, 4.7–19.8). Strong PSMA expression was found in tumour microvasculature (14/23, 61% in HGG, 13/20, 65% in BM). Tumour cell PSMA expression was found in a subset of HGG (10/23; of which strong in 8/10) and BM (3/20; none of which showed strong expression). Strong PSMA expression was also found on non-malignant glial cells in tumour. PSMA expression in healthy brain control samples was negligible. In HGG, a significant correlation existed between [ 68 Ga]Ga-PSMA-11 uptake and PSMA expression in tumour microvasculature (r = 0.487, P < 0.01), but not tumour cells.

Conclusion

PSMA expression in brain tumours is predominately vascular, which likely explains why microvascular (rather than tumour cell) PSMA expression correlates with [ 68 Ga]Ga-PSMA-11 uptake in HGG. This neovascular expression is crucial information for future PSMA-based RLT studies, as alpha-emitters may not sufficiently target tumour DNA. NCT05798273; date of registration: 1/9/2020.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, SurfaceBrain NeoplasmsEdetic AcidGene Expression Regulation, NeoplasticGliomaGlutamate Carboxypeptidase IIMagnetic Resonance ImagingPositron-Emission TomographyAdultAgedFemaleHumansMaleMiddle AgedBiological TransportGallium RadioisotopesImage-Guided BiopsyNeoplasm GradingProspective StudiesGallium Isotopes

Stichwörter der Autor:innen

Image-guided biopsy samplingImmunohistochemistryMalignant brain tumourPET-MRIProstate-specific membrane antigen

Substanzen

Antigens, SurfaceEdetic AcidFOLH1 protein, humangallium 68 PSMA-11Gallium RadioisotopesGlutamate Carboxypeptidase IIGallium Isotopes

Autor:innen und Institutionen

  • Department of Radiology and Nuclear Medicine, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
  • Brain Tumour Centre, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Department of Pathology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
  • Department of Pathology, Leiden University Medical Centre, Leiden, Netherlands.
  • Department of Neurosurgery, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
  • Department of Radiology and Nuclear Medicine, University Medical Centre Rotterdam, Rotterdam, The Netherlands. s.veldhuijzenvanzanten@erasmusmc.nl.

ORCID-Profile: Sophie E M Veldhuijzen van Zanten

Förderung

  • Semmy Foundation

Zitieren

APA

Pruis, I. J., van Dis, V., Maas, S. L. N., Balvers, R. K., van den Bosch, T. P. P., Segbers, M., & Veldhuijzen van Zanten, S. E. M. (2025). PSMA radioligand uptake correlates with PSMA expression in high-grade glioma and brain metastasis: insights from a prospective PET-MRI guided multiregional biopsy study. European Journal of Nuclear Medicine and Molecular Imaging, 52(13), 4870-4881. https://doi.org/10.1007/s00259-025-07338-4

Vancouver

Pruis IJ, van Dis V, Maas SLN, Balvers RK, van den Bosch TPP, Segbers M, et al. PSMA radioligand uptake correlates with PSMA expression in high-grade glioma and brain metastasis: insights from a prospective PET-MRI guided multiregional biopsy study. European Journal of Nuclear Medicine and Molecular Imaging. 2025;52(13):4870-4881. doi:10.1007/s00259-025-07338-4

BibTeX
@article{Pruis2025,
  author = {Pruis, Ilanah J and van Dis, Vera and Maas, Sybren L N and Balvers, Rutger K and van den Bosch, Thierry P P and Segbers, Marcel and Veldhuijzen van Zanten, Sophie E M},
  title = {PSMA radioligand uptake correlates with PSMA expression in high-grade glioma and brain metastasis: insights from a prospective PET-MRI guided multiregional biopsy study},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  volume = {52},
  number = {13},
  pages = {4870--4881},
  doi = {10.1007/s00259-025-07338-4}
}
Kostenlos starten →